Patients with chronic kidney disease (CKD) have a high prevalence of vascular calcification,
and cardiovascular disease is the leading cause of death in this population. However, the …

Cardiovascular complications are the leading cause of death in patients with chronic kidney
disease (CKD). Abundant experimental evidence suggests a physiological role of …

Vascular calcification (VC) is associated with elevated cardiovascular mortality rates in
patients with CKD. Recent clinical studies of patients with advanced CKD have observed an …

Vascular calcification is a prognostic marker for cardiovascular mortality in chronic kidney
disease (CKD) patients. In these patients, magnesium balance is disturbed, mainly due to …

Experimental and clinical studies have demonstrated that magnesium deficiency leads to
hypertension, insulin resistance, and endothelial dysfunction, and is associated with an …

Increasing evidence has suggested a clinical relevance of magnesium in the context of
vascular calcification and mortality among patients with CKD. Hypomagnesemia is not rare …

Background Vascular calcification is a key process involved in cardiovascular morbidity and
mortality in patients with chronic kidney disease (CKD). Magnesium supplementation may …

Over the last decade, an increasing number of studies report a close relationship between
serum magnesium concentration and cardiovascular disease risk in the general population …

Background Elevated levels of serum magnesium are associated with lower risk of
cardiovascular events in patients with CKD. Magnesium also prevents vascular calcification …

Background The aim of the study was to evaluate the impact of magnesium (Mg) on the
evolution of arterial calcifications in hemodialysis patients. Patients and methods Seventy …